NYSE:DOCS - New York Stock Exchange, Inc. - US26622P1075 - Common Stock - Currency: USD
53
-0.77 (-1.43%)
The current stock price of DOCS is 53 USD. In the past month the price increased by 1.15%. In the past year, price increased by 90.44%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.43 | 39.17B | ||
WAY | WAYSTAR HOLDING CORP | 50.19 | 6.86B | ||
CERT | CERTARA INC | 23.86 | 1.89B | ||
SDGR | SCHRODINGER INC | N/A | 1.58B | ||
PHR | PHREESIA INC | N/A | 1.50B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 11.68 | 1.43B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.29B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
EVH | EVOLENT HEALTH INC - A | 23.08 | 1.03B | ||
HSTM | HEALTHSTREAM INC | 45.48 | 874.68M | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 840.05M | ||
SLP | SIMULATIONS PLUS INC | 91.67 | 645.23M |
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 827 full-time employees. The company went IPO on 2021-06-24. The company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, stay up to date with the latest medical news and research and manage their careers. The company offers Marketing, Hiring, and Productivity Solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and certain other healthcare companies. Its Marketing Solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its Hiring Solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its Productivity Solutions include its telehealth, on-call scheduling, and artificial intelligence (AI)-supported medical correspondence tools and are designed to help clinicians streamline their clinical workflow.
DOXIMITY INC-CLASS A
500 Third Street
San Francisco CALIFORNIA US
CEO: Jeffrey Tangney
Employees: 827
Phone: 16505494330
The current stock price of DOCS is 53 USD. The price decreased by -1.43% in the last trading session.
The exchange symbol of DOXIMITY INC-CLASS A is DOCS and it is listed on the New York Stock Exchange, Inc. exchange.
DOCS stock is listed on the New York Stock Exchange, Inc. exchange.
26 analysts have analysed DOCS and the average price target is 73.68 USD. This implies a price increase of 39.02% is expected in the next year compared to the current price of 53. Check the DOXIMITY INC-CLASS A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DOXIMITY INC-CLASS A (DOCS) has a market capitalization of 9.94B USD. This makes DOCS a Mid Cap stock.
DOXIMITY INC-CLASS A (DOCS) currently has 827 employees.
DOXIMITY INC-CLASS A (DOCS) has a support level at 51.56 and a resistance level at 53.18. Check the full technical report for a detailed analysis of DOCS support and resistance levels.
The Revenue of DOXIMITY INC-CLASS A (DOCS) is expected to grow by 12.16% in the next year. Check the estimates tab for more information on the DOCS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DOCS does not pay a dividend.
DOXIMITY INC-CLASS A (DOCS) will report earnings on 2025-08-06, after the market close.
The PE ratio for DOXIMITY INC-CLASS A (DOCS) is 37.59. This is based on the reported non-GAAP earnings per share of 1.41 and the current share price of 53 USD. Check the full fundamental report for a full analysis of the valuation metrics for DOCS.
The outstanding short interest for DOXIMITY INC-CLASS A (DOCS) is 6.91% of its float. Check the ownership tab for more information on the DOCS short interest.
ChartMill assigns a technical rating of 4 / 10 to DOCS. When comparing the yearly performance of all stocks, DOCS is one of the better performing stocks in the market, outperforming 92.78% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to DOCS. Both the health and profitability get an excellent rating, making DOCS a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months DOCS reported a non-GAAP Earnings per Share(EPS) of 1.41. The EPS increased by 48.42% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 36.6% | ||
ROA | 17.18% | ||
ROE | 19.53% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 75% to DOCS. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of -5.27% and a revenue growth 12.16% for DOCS